Exelixis (EXEL) announces CONTACT-01 study did not meet its primary endpoint

Go back to Exelixis (EXEL) announces CONTACT-01 study did not meet its primary endpoint
Exelixis, Inc. (NASDAQ: EXEL) Delayed: 53.21 +0.89 (1.70%)
Previous Close $52.32    52 Week High $17.00 
Open $52.32    52 Week Low $3.55 
Day High $53.33    P/E N/A 
Day Low $52.11    EPS $-1.33 
Volume 365,702